JACK PAYNE: Open Payments
NPI 1548021801 · SUMMERVILLE, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,844 in 70 payments from 20 companies in 2025. Trend: 2023 $0 · 2024 $1,474 · 2025 $1,844
Food & beverage: $1,844
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 10 | $371 |
| AstraZeneca Pharmaceuticals LP | 13 | $296 |
| ABBVIE INC. | 14 | $272 |
| Philips North America LLC | 1 | $144 |
| Cagent Vascular INC | 1 | $144 |
| PFIZER INC. | 8 | $141 |
| Corcept Therapeutics | 5 | $116 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $78 |
| Otsuka America Pharmaceutical, Inc. | 2 | $46 |
| Astellas Pharma US Inc | 1 | $31 |
Products named: Ozempic, VRAYLAR, AIRSUPRA, Labosys, Serrantor, FARXIGA, Korlym, ELIQUIS.
Industry payments across SC — which companies pay providers there.
